These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7824484)

  • 1. [Hypereosinophilia and cutaneous lesions caused by low-molecular-weight heparin].
    Dacosta A; Mismetti P; Buchmuller A; Guy C; Buisson G; Decousus H
    Presse Med; 1994 Oct; 23(33):1540. PubMed ID: 7824484
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity.
    Palacios Colom L; Alcántara Villar M; Luis Anguita Carazo J; Ruiz Villaverde R; Quiralte Enríquez J
    Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893
    [No Abstract]   [Full Text] [Related]  

  • 3. [Eosinophilia caused by low-molecular-weight heparin].
    Marcos Sánchez F; Aparicio Martínez JC; Durán Pérez-Navarro A
    An Med Interna; 1992 May; 9(5):256. PubMed ID: 1324017
    [No Abstract]   [Full Text] [Related]  

  • 4. Type I and Type IV allergy to unfractionated heparin and low-molecular-weight heparin with no reaction to recombinant hirudin.
    Hallai N; Hughes TM; Stone N
    Contact Dermatitis; 2004 Sep; 51(3):153-4. PubMed ID: 15479209
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous allergic reaction to heparins: subcutaneous but not intravenous provocation.
    Maroto-Iitani M; Higaki Y; Kawashima M
    Contact Dermatitis; 2005 Apr; 52(4):228-30. PubMed ID: 15859998
    [No Abstract]   [Full Text] [Related]  

  • 6. Proliferative Sweet syndrome associated with pregnancy and low-molecular-weight heparin sodium.
    Zhang W; Wei S; Peng X; Xie S; Zeng K; Lai K
    Scand J Rheumatol; 2019 Sep; 48(5):428-429. PubMed ID: 30907689
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin lesions, hypereosinophilia, and subcutaneous heparin.
    Bircher AJ; Itin PH; Büchner SA
    Lancet; 1994 Apr; 343(8901):861. PubMed ID: 7908111
    [No Abstract]   [Full Text] [Related]  

  • 8. [Unfractionated standard heparin versus low molecular weight heparins].
    Schrader J; Haas S
    Internist (Berl); 1993 Nov; 34(11):1053-7; discussion 1058. PubMed ID: 8282491
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intravenous or subcutaneous heparin. What is better in deep venous thrombosis?].
    MMW Fortschr Med; 2002 Jun; 144(26):55. PubMed ID: 12154485
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-molecular-weight subcutaneous heparin-induced skin necrosis.
    Montserrat I; Lopez D; Zuazu-Jausoro I; Perez M; de Moragas JM; Fontcuberta J
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):751-2. PubMed ID: 1966800
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypereosinophilia and subcutaneous heparin.
    Giustolisi R; Guglielmo P; di Raimondo F; Cacciola E; Stagno F
    Lancet; 1993 Nov; 342(8883):1371. PubMed ID: 7901670
    [No Abstract]   [Full Text] [Related]  

  • 12. Skin necrosis after subcutaneous low molecular weight heparin injection.
    Real E; Grau E; Rubio M; Torrecilla T
    Am J Hematol; 1995 Jul; 49(3):253-4. PubMed ID: 7604821
    [No Abstract]   [Full Text] [Related]  

  • 13. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
    Maetzke J; Hinrichs R; Schneider LA; Scharffetter-Kochanek K
    Allergy; 2005 Mar; 60(3):413-5. PubMed ID: 15679737
    [No Abstract]   [Full Text] [Related]  

  • 14. Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover study.
    Palese A; Aidone E; Dante A; Pea F
    J Cardiovasc Nurs; 2013; 28(5):473-82. PubMed ID: 22760174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Heparin after deep venous thrombosis. Even the first injection the patient can administer himself].
    MMW Fortschr Med; 1999 Dec; 141(51-52):62. PubMed ID: 10949629
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-molecular-weight heparin in pregnancy.
    Kittisupamongkol W
    Am J Obstet Gynecol; 2009 Sep; 201(3):e12; author reply e12. PubMed ID: 19439265
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy.
    Schapkaitz E; Jacobson BF
    S Afr Med J; 2007 Dec; 97(12):1255-7. PubMed ID: 18271118
    [No Abstract]   [Full Text] [Related]  

  • 19. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased wound healing disorders in patients with inguinal hernia caused by administration of antithrombotic agents in the abdominal wall].
    Lemke H; Imhoff M; Löhlein D
    Chirurg; 1994 Aug; 65(8):714-6. PubMed ID: 7956538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.